Daphne Karydas – Biography
Last update: March 24, 2026Executive profile
Daphne was President and Chief Financial Officer at Flare Therapeutics, and Chief Financial Officer at Syndax Pharmaceuticals. Daphne Karydas joined Mineralys Therapeutics in 2023.
Daphne Karydas is currentlyPresident and Chief Financial Officer at Flare Therapeutics - View - Flare Therapeutics org chart
Director at Mineralys Therapeutics - View - Mineralys Therapeutics org chart
Create your alert
to follow the career of Daphne Karydas.
Education
Daphne Karydas has a Master of Science in Chemical Engineering from Massachusetts Institute of Technology and a Master of Business Administration from Harvard Business School.
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
They have also studied at Harvard Business School :
Find more alumni from Harvard Business School
More about Daphne Karydas
Selected links
Do you need to know more about Daphne Karydas? More results.
Participate
Social media
- Daphne Karydas on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Daphne Karydas
The colleagues of Daphne Karydas
Company Colleagues
- At Flare Therapeutics, Daphne Karydas has 34 colleagues including Douglas Manion (CEO & Director), Abbie Celniker (Chairman of the Board)…
- At Mineralys Therapeutics, Daphne Karydas has 27 colleagues including Jon Congleton (CEO), BT Slingsby (Director)…
Industry Colleagues
- In the Biotechnology industry, Daphne Karydas has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Daphne Karydas.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Daphne Karydas.
